Lifecore Biomedical raises $24.3M through private placement for working capital and growth.

Lifecore Biomedical has secured $24.3 million through a private placement, selling 5,928,775 shares at $4.10 each to new and existing investors. The funds will support working capital, operations, and corporate purposes, aiding the company's growth in the pharmaceutical services sector. CEO Paul Josephs expressed appreciation for investor confidence in the management team and the company's future prospects.

October 04, 2024
9 Articles